-+ 0.00%
-+ 0.00%
-+ 0.00%

Australia's Telix Pharmaceuticals announced on September 21, 2026 that it has agreed to acquire German radioisotope supplier ITM Isotope Technologies Munich SE on a transaction with a total value of up to US$2.35 billion.

Zhitongcaijing·09/21/2026 00:01:09
Listen to the news
Australia's Telix Pharmaceuticals announced on September 21, 2026 that it has agreed to acquire German radioisotope supplier ITM Isotope Technologies Munich SE on a transaction with a total value of up to US$2.35 billion.